We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

FDA Approves New Drug for Hodgkin Lymphoma

News   Apr 20, 2017 | Original story from National Cancer Institute

 
FDA Approves Pembrolizumab for Hodgkin Lymphoma

Anatomical illustration of lymphoma. Credit: Terese Winslow

 
 
Advertisement
 

RELATED ARTICLES

Like a Stamped Passport, SARS-Cov-2 Mutations Tell a Tale of Its Transmission in the US

News

The coronavirus, responsible for the COVID-19 pandemic, has one official name—SARS-CoV-2. But according to virologists, mutations lead to hundreds of genetically-distinct versions of the virus. Scientists at Children’s Hospital Los Angeles have used these viral signatures to reveal transmission patterns, which show the effectiveness of early safety measure policies.

READ MORE

Ancient DNA Elements Can Activate a Powerful Immune Response to Cancer Cells

News

Ancient embedded elements in our DNA from generations past can activate a powerful immune response to kill cancer cells like an infection.

READ MORE

AI Platform Matches Tumor to Most Effective Drug Combo

News

Only 4 percent of all cancer therapeutic drugs under development earn final approval by the U.S. Food and Drug Administration (FDA). Ideker and Brent Kuenzi, PhD, and Jisoo Park, PhD, postdoctoral researchers in his lab, describe DrugCell, a new artificial intelligence (AI) system they created that not only matches tumors to the best drug combinations, but does so in a way that makes sense to humans.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE